Nasdaq · CIK 0001362190
AEYE AUDIOEYE INC
Insider trading from SEC Form 4. Last filing 10 d ago. Close $6.93 on Oct 9, 2026, +28% from the 52-week low and -55% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
8
with a Form 4 at this company
Price and insider trades, last year
AEYEOct 9, 2026 · close 6.93
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at AUDIOEYE INC, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | James B Hawkins director buy | $205k 13,300 shares | +13% | +7% from low-65% from high | |
| 75Notable | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD sell | $5.4M 225,000 shares | -53% | - | |
| 75Notable | David Moradi CHIEF EXECUTIVE OFFICER sell | $22M 900,000 shares | -33% | - | |
| 65Notable | Jamil A. Tahir director sell | $3.0M 125,000 shares | -39% | - | |
| 58Moderate | David Moradi CHIEF EXECUTIVE OFFICER sell | $3.8M 134,043 shares | -5% | - | |
| 49Moderate | Kelly Georgevich CHIEF FINANCIAL OFFICER sell | $304k 10,500 shares | -11% | - |
Transactions
The last 76 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Jamil A. Tahir director | AGrant or award Common Stock | +2,100 | $0.00 | $0 | 151,357 | 10 d ago |
| Oct 1, 2026 | James B Hawkins director | AGrant or award Common Stock | +1,000 | $0.00 | $0 | 218,684 | 10 d ago |
| Sep 30, 2026 | Matthew Domeyer Chief Financial Officer | FTax withholding Common Stock | -1,070 | $6.72 | $7,190 | 16,930 | 10 d ago |
| Sep 30, 2026 | Kelly Georgevich CEO AND SECRETARY | FTax withholding Common Stock | -3,044 | $6.72 | $20k | 167,576 | 10 d ago |
| Oct 1, 2026 | Katherine E. Fleming director | AGrant or award Common Stock | +1,300 | $0.00 | $0 | 46,628 | 10 d ago |
| Sep 30, 2026 | David Moradi EXECUTIVE CHAIRMAN AND CPO | FTax withholding Common Stock | -5,706 | $6.72 | $38k | 797,595 | 10 d ago |
| Jun 21, 2025 | Kelly Georgevich CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -6,308 | $11.81 | $74k | 105,196 | Jun 24, 2025 |
| Jun 20, 2025 | James B Hawkins director | XIn-the-money exercise Common Stock | +1,000 | $16.00 | $16k | 129,916 | Jun 24, 2025 |
| Jun 20, 2025 | James B Hawkins director | XIn-the-money exercise Common Stock | +7,600 | $15.00 | $114k | 137,516 | Jun 24, 2025 |
| Jun 20, 2025 | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -10 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -76 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | James B Hawkins director | EExpiration of short derivative Put Option (obligation to buy)derivative | -10 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 12, 2025 | James B Hawkins director | XIn-the-money exercise Common Stock | +1,000 | $15.00 | $15k | 123,516 | Jun 17, 2025 |
| Jun 13, 2025 | James B Hawkins director | XIn-the-money exercise Common Stock | +5,400 | $15.00 | $81k | 128,916 | Jun 17, 2025 |
| Jun 12, 2025 | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -10 | $0.00 | $0 | 13,000 | Jun 17, 2025 |
| Jun 13, 2025 | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -54 | $0.00 | $0 | 7,600 | Jun 17, 2025 |
| May 23, 2025 | Katherine E. Fleming director | AGrant or award Common Stock | +5,667 | $0.00 | $0 | 32,060 | Jun 5, 2025 |
| May 23, 2025 | James B Hawkins director | AGrant or award Common Stock | +5,667 | $0.00 | $0 | 122,516 | Jun 5, 2025 |
| May 23, 2025 | Jamil A. Tahir director | AGrant or award Common Stock | +8,500 | $0.00 | $0 | 128,807 | Jun 5, 2025 |
| May 23, 2025 | Jamil A. Tahir director | AGrant or award Common Stock | +8,500 | $0.00 | $0 | 128,807 | May 28, 2025 |
| May 23, 2025 | Katherine E. Fleming director | AGrant or award Common Stock | +5,667 | $0.00 | $0 | 32,060 | May 28, 2025 |
| May 23, 2025 | James B Hawkins director | AGrant or award Common Stock | +5,667 | $0.00 | $0 | 122,516 | May 28, 2025 |
| Apr 30, 2025 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | AGrant or award Common Stock | +772 | $0.00 | $0 | 454,626 | May 2, 2025 |
| Apr 30, 2025 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | FTax withholding Common Stock | -229 | $10.85 | $2,485 | 454,397 | May 2, 2025 |
| Apr 1, 2025 | Jamil A. Tahir director | AGrant or award Common Stock | +1,400 | $0.00 | $0 | 120,307 | Apr 3, 2025 |
| Apr 1, 2025 | Katherine E. Fleming director | AGrant or award Common Stock | +867 | $0.00 | $0 | 26,393 | Apr 3, 2025 |
| Apr 1, 2025 | James B Hawkins director | AGrant or award Common Stock | +667 | $0.00 | $0 | 116,849 | Apr 3, 2025 |
| Mar 31, 2025 | David Moradi CHIEF EXECUTIVE OFFICER | AGrant or award Common Stock | +241,444 | $0.00 | $0 | 1,105,867 | Apr 2, 2025 |
| Mar 31, 2025 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | AGrant or award Common Stock | +772 | $0.00 | $0 | 454,083 | Apr 2, 2025 |
| Mar 31, 2025 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | FTax withholding Common Stock | -229 | $11.10 | $2,542 | 453,854 | Apr 2, 2025 |
| Mar 28, 2025 | Kelly Georgevich CHIEF FINANCIAL OFFICER | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 111,504 | Apr 1, 2025 |
| Mar 21, 2025 | James B Hawkins director | XIn-the-money exercise Common Stock | +1,800 | $15.00 | $27k | 116,182 | Mar 25, 2025 |
| Mar 21, 2025 | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -18 | $0.00 | $0 | 0 | Mar 25, 2025 |
| Mar 19, 2025 | James B Hawkins director | POpen-market purchase Common Stock | +11,200 | $15.00 | $168k | 112,282 | Mar 21, 2025 |
| Mar 19, 2025 | James B Hawkins director | POpen-market purchase Common Stock | +2,100 | $17.50 | $37k | 114,382 | Mar 21, 2025 |
| Mar 19, 2025 | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -112 | $0.00 | $0 | 1,800 | Mar 21, 2025 |
| Mar 19, 2025 | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -21 | $0.00 | $0 | 0 | Mar 21, 2025 |
| Mar 14, 2025 | James B Hawkins director | XIn-the-money exercise Common Stock | +3,900 | $17.50 | $68k | 101,082 | Mar 17, 2025 |
| Mar 14, 2025 | James B Hawkins director | XIn-the-money exercise Put Option (obligation to buy)derivative | -39 | $0.00 | $0 | 2,100 | Mar 17, 2025 |
| Mar 3, 2025 | James B Hawkins director | AGrant or award Common Stock | +215 | $0.00 | $0 | 95,912 | Mar 5, 2025 |
| Mar 3, 2025 | Katherine E. Fleming director | AGrant or award Common Stock | +64 | $0.00 | $0 | 25,526 | Mar 5, 2025 |
| Mar 3, 2025 | James B Hawkins director | AGrant or award Common Stock | +1,270 | $0.00 | $0 | 97,182 | Mar 5, 2025 |
| Feb 28, 2025 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | AGrant or award Common Stock | +772 | $0.00 | $0 | 453,540 | Mar 4, 2025 |
| Feb 28, 2025 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | FTax withholding Common Stock | -229 | $13.01 | $2,979 | 453,311 | Mar 4, 2025 |
| Jan 31, 2025 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | AGrant or award Common Stock | +772 | $0.00 | $0 | 452,997 | Feb 4, 2025 |
| Jan 31, 2025 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | FTax withholding Common Stock | -229 | $18.94 | $4,337 | 452,768 | Feb 4, 2025 |
| Jan 20, 2025 | David Moradi CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -35,725 | $17.22 | $615k | 864,423 | Jan 22, 2025 |
| Jan 1, 2025 | Jamil A. Tahir director | AGrant or award Common Stock | +1,400 | $0.00 | $0 | 118,907 | Jan 3, 2025 |
| Jan 1, 2025 | Anthony L Coelho director | AGrant or award Common Stock | +867 | $0.00 | $0 | 195,261 | Jan 3, 2025 |
| Jan 1, 2025 | Katherine E. Fleming director | AGrant or award Common Stock | +667 | $0.00 | $0 | 25,462 | Jan 3, 2025 |
| Dec 31, 2024 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | AGrant or award Common Stock | +772 | $0.00 | $0 | 452,454 | Jan 3, 2025 |
| Dec 31, 2024 | Kelly Georgevich CHIEF FINANCIAL OFFICER | FTax withholding Common Stock | -1,977 | $15.21 | $30k | 96,504 | Jan 3, 2025 |
| Dec 31, 2024 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | FTax withholding Common Stock | -229 | $15.21 | $3,483 | 452,225 | Jan 3, 2025 |
| Dec 18, 2024 | Kelly Georgevich CHIEF FINANCIAL OFFICER | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 98,481 | Dec 20, 2024 |
| Dec 18, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | AGrant or award Common Stock | +55,000 | $0.00 | $0 | 917,906 | Dec 20, 2024 |
| Dec 18, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | FTax withholding Common Stock | -17,758 | $16.40 | $291k | 900,148 | Dec 20, 2024 |
| Dec 4, 2024 | Jamil A. Tahir director | SOpen-market sale Common Stockindirect: Through TurnMark Partners L.P. | -125,000 | $24.00 | $3.0M | 195,000 | Dec 6, 2024 |
| Dec 4, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -900,000 | $24.00 | $22M | 1,864,290 | Dec 6, 2024 |
| Dec 4, 2024 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | SOpen-market sale Common Stockindirect: CSB IV US Holdings LLC | -225,000 | $24.00 | $5.4M | 200,045 | Dec 6, 2024 |
| Nov 30, 2024 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | AGrant or award Common Stock | +772 | $0.00 | $0 | 451,986 | Dec 3, 2024 |
| Nov 30, 2024 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | FTax withholding Common Stock | -304 | $26.92 | $8,184 | 451,682 | Dec 3, 2024 |
| Nov 12, 2024 | Kelly Georgevich CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock | -10,000 | $29.00 | $290k | 88,981 | Nov 14, 2024 |
| Nov 12, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -38,132 | $28.76 | $1.1M | 2,860,201 | Nov 14, 2024 |
| Nov 14, 2024 | Kelly Georgevich CHIEF FINANCIAL OFFICER | SOpen-market sale Common Stock | -500 | $27.00 | $14k | 88,481 | Nov 14, 2024 |
| Nov 12, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -18,397 | $29.72 | $547k | 2,841,804 | Nov 14, 2024 |
| Nov 12, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -5,125 | $30.72 | $157k | 2,836,679 | Nov 14, 2024 |
| Nov 12, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -4,445 | $31.76 | $141k | 2,832,234 | Nov 14, 2024 |
| Nov 12, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -2,199 | $32.68 | $72k | 2,830,035 | Nov 14, 2024 |
| Nov 13, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -40,228 | $26.56 | $1.1M | 2,789,807 | Nov 14, 2024 |
| Nov 13, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -9,267 | $27.57 | $256k | 2,780,540 | Nov 14, 2024 |
| Nov 13, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -2,189 | $28.40 | $62k | 2,778,351 | Nov 14, 2024 |
| Nov 14, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -7,132 | $25.72 | $183k | 2,771,219 | Nov 14, 2024 |
| Nov 14, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -6,718 | $26.54 | $178k | 2,764,501 | Nov 14, 2024 |
| Nov 14, 2024 | David Moradi CHIEF EXECUTIVE OFFICER | SOpen-market sale Common Stockindirect: Through Sero Capital LLC | -211 | $27.26 | $5,752 | 2,764,290 | Nov 14, 2024 |
| Oct 31, 2024 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | AGrant or award Common Stock | +772 | $0.00 | $0 | 451,518 | Nov 4, 2024 |
| Oct 31, 2024 | Carr Bettis EXEC CHRMN/CHRMN OF THE BOARD | FTax withholding Common Stock | -304 | $21.30 | $6,475 | 451,214 | Nov 4, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Carr BettisEXEC CHRMN/CHRMN OF THE BOARD
- Anthony L Coelhodirector
- Matthew DomeyerChief Financial Officer
- Katherine E. Flemingdirector
- Kelly GeorgevichCHIEF FINANCIAL OFFICER
- James B Hawkinsdirector
- David MoradiCHIEF EXECUTIVE OFFICER
- Jamil A. Tahirdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.